Literature DB >> 32207093

Incidence, gender influence, and neuropsychological predictors of all cause dementia in the Faroe Islands-the Faroese Septuagenarian cohort.

Kimberly C Paul1, Fróði Debes2, Eina Eliasen2, Pál Weihe2,3, Maria Skaalum Petersen4,5.   

Abstract

BACKGROUND: Using the Faroese Septuagenarian cohort, we aimed to describe the incidence of dementia and assess the validity of neurocognitive tests to predict subsequent dementia diagnosis.
METHODS: In this population-based cohort, 713 Faroese septuagenarians aged 70-74 years without dementia, underwent clinical and neuropsychological examinations. After 10-years of follow-up, information was collected on all participants referred for cognitive evaluations and diagnosed with dementia. Incidence rates were calculated and presented with 95% confidence intervals (CIs), assuming a Poisson distribution. We then performed discriminant analysis to determine the best set of neuropsychological tests to identify those who would develop dementia.
RESULTS: Over the 10-years, 65 participants (9.1%) were diagnosed with dementia, with a 10-year incidence rate of 1063 cases per 100,000 person years (95% CI 825, 1343). Women had a greater incidence than men (incidence rate ratio (IRR) = 1.58; 95% CI 0.93, 2.71). After stepwise selection, gender and six neuropsychological measures were selected to discriminate between those who would and would not develop dementia. Overall, the model was able to correctly identify 82% of those who would not develop dementia (specificity) and 71% of those who would (sensitivity).
CONCLUSIONS: These results indicate that among a greater number of tests covering a broad range of cognitive abilities, tests reflecting verbal and visual learning and recall, visuospatial function, attention, and encoding into and retrieval from long-term memory may be helpful in identifying patients in the pre-symptomatic phase of dementia. Thus, helping care-givers identify patients at a higher risk of developing dementia and adjusting management of care accordingly.

Entities:  

Keywords:  Alzheimer’s disease; Dementia; Faroe Islands; Incidence; Neuropsychological tests

Mesh:

Year:  2020        PMID: 32207093      PMCID: PMC7508821          DOI: 10.1007/s40520-020-01520-4

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  29 in total

1.  Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland.

Authors:  J T Salonen; K Seppänen; T A Lakka; R Salonen; G A Kaplan
Journal:  Atherosclerosis       Date:  2000-02       Impact factor: 5.162

2.  Qualitative patterns at Raven's colored progressive matrices in mild cognitive impairment and Alzheimer's disease.

Authors:  Ferdinando Ivano Ambra; Alessandro Iavarone; Bruno Ronga; Sergio Chieffi; Gabriele Carnevale; Leonardo Iaccarino; Francesco Cimminella; Angela Chiavazzo; Elisabetta Garofalo
Journal:  Aging Clin Exp Res       Date:  2015-08-22       Impact factor: 3.636

Review 3.  Early neuropsychological detection of Alzheimer's disease.

Authors:  C Bastin; E Salmon
Journal:  Eur J Clin Nutr       Date:  2014-09-03       Impact factor: 4.016

4.  Trends in dementia incidence: Evolution over a 10-year period in France.

Authors:  Leslie Grasset; Carol Brayne; Pierre Joly; Hélène Jacqmin-Gadda; Karine Peres; Alexandra Foubert-Samier; Jean-François Dartigues; Catherine Helmer
Journal:  Alzheimers Dement       Date:  2015-12-13       Impact factor: 21.566

5.  Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented.

Authors:  P Chen; G Ratcliff; S H Belle; J A Cauley; S T DeKosky; M Ganguli
Journal:  Neurology       Date:  2000-12-26       Impact factor: 9.910

6.  Gender differences in cognitive performance and health status in the Faroese Septuagenarians cohort.

Authors:  Maria Skaalum Petersen; Fróði Debes; Philippe Grandjean; Pál Weihe
Journal:  Eur J Public Health       Date:  2019-02-01       Impact factor: 3.367

Review 7.  Recent global trends in the prevalence and incidence of dementia, and survival with dementia.

Authors:  Martin Prince; Gemma-Claire Ali; Maëlenn Guerchet; A Matthew Prina; Emiliano Albanese; Yu-Tzu Wu
Journal:  Alzheimers Res Ther       Date:  2016-07-30       Impact factor: 6.982

Review 8.  Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis.

Authors:  Cláudia Y Santos; Peter J Snyder; Wen-Chih Wu; Mia Zhang; Ana Echeverria; Jessica Alber
Journal:  Alzheimers Dement (Amst)       Date:  2017-02-09

9.  Methylmercury exposure and adverse cardiovascular effects in Faroese whaling men.

Authors:  Anna L Choi; Pal Weihe; Esben Budtz-Jørgensen; Poul J Jørgensen; Jukka T Salonen; Tomi-Pekka Tuomainen; Katsuyuki Murata; Hans Petur Nielsen; Maria Skaalum Petersen; Jórun Askham; Philippe Grandjean
Journal:  Environ Health Perspect       Date:  2008-10-16       Impact factor: 9.031

10.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.

Authors:  Sam Norton; Fiona E Matthews; Deborah E Barnes; Kristine Yaffe; Carol Brayne
Journal:  Lancet Neurol       Date:  2014-08       Impact factor: 44.182

View more
  1 in total

1.  Gender-specific clinical risk scores incorporating blood pressure variability for predicting incident dementia.

Authors:  Jiandong Zhou; Sharen Lee; Wing Tak Wong; Khalid Bin Waleed; Keith Sai Kit Leung; Teddy Tai Loy Lee; Abraham Ka Chung Wai; Tong Liu; Carlin Chang; Bernard Man Yung Cheung; Qingpeng Zhang; Gary Tse
Journal:  J Am Med Inform Assoc       Date:  2022-01-12       Impact factor: 7.942

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.